Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2012
03/08/2012US20120056171 Compound for organic photoelectric device and organic photoelectric device including the same
03/08/2012US20120055079 Products from step-wise extraction of algal biomasses
03/08/2012CA2810071A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012CA2810011A1 Adsorption of immunopotentiators to insoluble metal salts
03/08/2012CA2809911A1 Bicyclic aza heterocycles, and use thereof
03/08/2012CA2809892A1 Pyrazolopyridinone derivatives as lpa receptor antagonists
03/08/2012CA2809836A1 Pyridinones/pyrazinones, method of making, and method of use thereof
03/08/2012CA2809662A1 Pyridazinones, method of making, and method of use thereof
03/07/2012EP2426191A1 Process for the homogenous hydrogenation of (poly)unsaturated hydrocarbons
03/07/2012EP2426129A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
03/07/2012EP2426125A1 1,4 disubstituted 3 cyano pyridone derivatives and their use as positive allosteric modulators of mGluR2 receptors
03/07/2012EP2425840A1 Triazine derivatives and their therapeutical applications
03/07/2012EP2424869A1 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
03/07/2012EP2424868A1 Cdk inhibitor salts
03/07/2012EP2424867A1 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
03/07/2012EP2424866A1 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
03/07/2012EP2424537A1 Substituted imidazoquinoxalines
03/07/2012EP2424368A1 Pyrrolotriazine compounds
03/07/2012EP2213674B1 Purification method of pemetrexed salts,sodium salts and disodium salts
03/07/2012EP2175859B1 Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
03/07/2012EP2111402B1 Aminopyrazole kinase inhibitors
03/07/2012EP1982986B1 Pyrrolopyridazinone compound as pde4 inhibitor
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012EP0885192B1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
03/07/2012CN102369205A Fused ring compound and use thereof
03/07/2012CN102369192A Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/07/2012CN102369191A Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/06/2012US8129530 Catecholamine derivatives and prodrugs thereof
03/06/2012US8129520 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
03/06/2012US8129398 HIV integrase inhibitors
03/06/2012US8129386 Fused azole-pyrimidine derivatives
03/06/2012US8129382 Compounds, methods and pharmaceutical compositions for inhibiting PARP
03/06/2012US8129379 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/06/2012US8129371 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/01/2012WO2012027593A1 Electron-deficient fluorous porphyrins and methods of making and their use in organic solar cells
03/01/2012WO2012025944A2 Sitagliptin, salts and polymorphs thereof
03/01/2012WO2012025186A1 Triazolopyrazine derivatives
03/01/2012WO2011161537A3 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof
03/01/2012WO2011090333A9 Chlorine derivative/unsaturated fatty acid conjugates, photosensitizers comprising same, and cancer treatment compositions to be used in photodynamic therapy comprising same
03/01/2012US20120053345 Indazole Compounds
03/01/2012US20120053344 Methods for producing phycotoxins
03/01/2012US20120053219 Processes of making and using pharmaceutical formulations of antineoplastic agents
03/01/2012US20120053189 Btk inhibitors for the treatment of immune mediated conditions
03/01/2012US20120053175 Mlk inhibitors and methods of use
03/01/2012US20120053171 Nitrogen-Containing Fused Heterocyclic Compounds and Their use as Beta Amyloid Production Inhibitors
03/01/2012US20120053168 Fused benzoazepines as neuronal nicotinic acetylcholine receptor ligands
03/01/2012CA2809331A1 Triazolopyrazine derivatives
02/2012
02/29/2012EP2423190A1 Compounds Exhibiting PGD 2 Receptor Antagonism
02/29/2012EP2423178A1 Process for the production of sitagliptin
02/29/2012EP2421870A2 Modulators of 5-ht receptors and methods of use thereof
02/29/2012EP2421867A2 Piperidine inhibitors of janus kinase 3
02/29/2012EP2421829A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
02/29/2012EP1953148B1 Heterocyclic amide compound and use thereof
02/29/2012EP1532153B1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/29/2012CN102365285A 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
02/29/2012CN102365280A New adenosine receptor ligands and uses thereof
02/29/2012CN102365277A Inhibitors of jun n-terminal kinase
02/29/2012CN102363619A Water soluble protoporphyrin compound and preparation method and use thereof
02/29/2012CN102363618A Novel inhibitor of epidermal growth factor receptor (EGFR) and application thereof
02/29/2012CN101516886B Thiophene pyrazolopyrimidine compounds
02/29/2012CN101346380B Pyrimidine derivatives for the treatment of abnormal cell growth
02/29/2012CN101273041B Luminescent vargula luciferin substrate and process for producing the same
02/29/2012CN101125855B Method for separating hemporfin isomer and separated isomer
02/29/2012CN101060838B Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
02/28/2012US8124773 1,8-naphthyridine compounds for the treatment of cancer
02/28/2012US8124760 Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process
02/28/2012US8124759 Inhibitors of protein kinases
02/28/2012US8124746 Methods and kits using extended rhodamine dyes
02/28/2012US8124620 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
02/28/2012US8124619 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
02/28/2012US8124618 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
02/28/2012US8124600 5-HT3 receptor modulators, methods of making, and use thereof
02/28/2012CA2614907C Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
02/23/2012WO2012024615A1 Nicotinic receptor compounds
02/23/2012WO2012024150A1 Oxadiazole inhibitors of leukotriene production
02/23/2012WO2012022707A1 Substituted heteroaryl spiropyrrolidine mdm2 antagonists
02/23/2012WO2012022299A1 Molecular switch
02/23/2012WO2012022265A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012WO2011158044A3 Respiratory formulations containing p38 mapk inhibitors
02/23/2012US20120046306 Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists
02/23/2012US20120046295 Compounds useful as inhibitors of atr kinase
02/23/2012US20120046294 Compounds for the Treatment of Hepatitis C
02/23/2012US20120046278 Thiazolopyrimidine modulators as immunosuppressive agents
02/23/2012US20120046271 2,5-Methano- and 2,5-Ethano-Tetrahydrobenzazepine Derivatives And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, and Serotonin
02/23/2012US20120046267 7-aminofuropyridine derivatives
02/23/2012US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof
02/23/2012US20120045509 Modified release compositions for dpp-iv inhibitors
02/23/2012CA2809028A1 Nicotinic receptor compounds
02/23/2012CA2808543A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012CA2807364A1 Oxadiazole inhibitors of leukotriene production
02/22/2012EP2419431A1 Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof
02/22/2012EP2419430A2 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
02/22/2012EP2419429A1 Imidazopyrazines for use as kinase inhibitors
02/22/2012EP2326644B1 Urotensin ii receptor antagonists
02/22/2012EP2093228B1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
02/22/2012EP1668013B1 Pyrazolopyrrole derivatives as protein kinase inhibitors
02/22/2012EP1523528B1 Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds
02/22/2012EP0986384B1 Inhibitors of protein isoprenyl transferases
02/22/2012CN102362314A Diketopyrrolopyrrole polymers for use in organic semiconductor devices
1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 573